Form EFFECT Biodexa Pharmaceuticals
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | September 30, 2026 5:00 P.M. |
| Form: | F-1 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- nVent Completes Acquisition of Maverick Power
- Independent Study Identifies Significant Potential Benefits from Triple Point Resources' Fischells Salt Dome Power Generation Project for Newfoundland and Labrador's Electricity System
- Ahead of Prime Big Deal Days, iSpring Launches Early Deals on Home Water Filtration Solutions for Modern Households
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share